AWKWARD: Dem Governor Celebrates Republicans Win

Virginia Governor Abigail Spanberger signed legislation this week authorizing 7.1 billion dollars in business investments, but the companies making those commitments announced their plans under her Republican predecessor, Glenn Youngkin, creating a political firestorm about who deserves credit for Virginia’s economic gains.

Story Snapshot

Governor Spanberger signed four bipartisan bills on April 7 formalizing major investments from Avio USA, Hitachi Energy, Eli Lilly, and AstraZeneca totaling 7.1 billion dollars and 3,250 jobs
All four companies announced their Virginia investments in 2025 under Governor Youngkin and explicitly thanked his administration for enabling the deals
Conservative media outlets criticized Spanberger for claiming credit, calling her announcement “pathetic” and highlighting her 47 percent approval rating as motivation for the move
The bills provide state incentives and were passed bipartisanly in 2026, but Spanberger’s role was primarily ceremonial since deal negotiations occurred under the previous administration

The Credit Grab That Backfired

On Monday, April 7, Governor Spanberger held a press conference celebrating her signature on legislation that would bring pharmaceutical manufacturing, electrical grid infrastructure, and solid rocket motor production to Virginia. She framed the announcement as evidence of her administration’s success in creating a stable business environment. The four bills represented a stunning economic win: 3,250 jobs across aerospace, energy, and pharmaceutical sectors, concentrated in rural areas of Southern Virginia that desperately need economic development. Yet within hours, critics began pointing out an uncomfortable fact: these companies had committed to Virginia under her predecessor.

Avio USA announced its 537 million dollar investment in Pittsylvania County in February 2026, but the original commitment came in 2025 under Youngkin. Hitachi Energy, Eli Lilly, and AstraZeneca followed similar timelines, each publicly thanking Governor Youngkin and his team for supporting their expansion plans. AstraZeneca’s CEO specifically praised Youngkin’s “energy and vision.” The investments weren’t hypothetical or contingent. They were done deals requiring only legislative formalization under the new governor.

Political Timing and Approval Ratings

The timing raises legitimate questions about motivation. Spanberger’s approval rating sits at 47 percent with 46 percent disapproving, according to a Washington Post-Schar School poll released around the same time as her announcement. In her first months as governor, she inherited a 2.7 billion dollar budget surplus and an economy already energized by Youngkin’s pro-business policies. Critics argue she needed a visible economic win to establish her own record, making the investment announcement irresistible despite its origins.

Spanberger’s statement in the press release claimed she had “been working to create a stable business environment so companies can hire, expand, and continue to invest in our Commonwealth.” The language carefully avoided claiming she negotiated the deals themselves, but the overall messaging suggested her administration earned credit for attracting and retaining these massive investments. Conservative outlets immediately pounced on what they characterized as political opportunism.

The Bipartisan Complication

The narrative becomes murkier when examining what Spanberger actually did. While the companies announced investments under Youngkin, Spanberger’s administration did sign legislation providing state incentives through four separate bills. These weren’t rubber stamps. The bills allocated specific financial support: over 2 billion dollars for Eli Lilly’s pharmaceutical manufacturing, 457 million for Hitachi Energy’s grid infrastructure, 537 million for Avio’s rocket motor production, and 4 billion for AstraZeneca’s medication manufacturing. The legislation passed bipartisanly through Virginia’s General Assembly, suggesting genuine policy work occurred in 2026.

Youngkin’s spokesman declined to make a fuss about the credit issue, noting gratitude that Virginia would continue reaping the benefits of investments secured during his tenure. This gracious response contrasts sharply with the partisan fury erupting across conservative media platforms, where commentators called Spanberger’s announcement pathetic and accused her of stealing economic credit from her predecessor.

What Voters Should Actually Care About

Beneath the partisan blame game lies a genuine economic story. Three thousand jobs in high-wage sectors represent real opportunity for Virginians, particularly in rural counties like Pittsylvania, Halifax, Goochland, and Albemarle that have struggled with economic stagnation. Avio’s 1,500 jobs in rocket motor production position Virginia as a critical player in aerospace and defense, aligning with national priorities. Eli Lilly’s pharmaceutical manufacturing creates 450 positions in an industry offering substantial wages and benefits. These investments will generate tax revenue, support local businesses, and provide career pathways for workers across the state.

OF COURSE: New Virginia Governor Abigail Spanberger Takes Credit for Investments Secured by Her Republican Predecessor Glenn Youngkin https://t.co/r3d8Lc9Yjh #gatewaypundit via @gatewaypundit
Stolen valor, again.

— Michael Hayes (@michael571062) April 10, 2026

The political fight over credit obscures what actually matters: whether these investments materialize as promised and whether the state’s incentives represent sound fiscal policy. Spanberger inherited strong economic momentum from her predecessor and had the good sense not to derail it. Whether she actively attracted these companies or simply managed their arrival competently remains debatable. What’s undeniable is that Virginia’s business-friendly policies, developed and executed under Youngkin’s administration, created the conditions for companies to commit billions in capital. Spanberger’s role was to maintain that environment and formalize the commitments through legislation. That’s neither nothing nor everything.